StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE:BTX opened at $6.54 on Friday. The company has a market cap of $384.72 million, a P/E ratio of -2.88 […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE:BTX opened at $6.54 on Friday. The company has a market cap of $384.72 million, a P/E ratio of -2.88 […]
